Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/wiley/dutch-brain-research-registry-for-study-participant-recruitment-design-RQKEY6aWd6
References (55)
-
A. Gilmore-Bykovskyi, Yuanyuan Jin, C. Gleason, S. Flowers-Benton, L. Block, P. Dilworth-Anderson, L. Barnes, Manish Shah, M. Zuelsdorff (2019)
Recruitment and retention of underrepresented populations in Alzheimer's disease research: A systematic reviewAlzheimer's & Dementia : Translational Research & Clinical Interventions, 5
-
( Johnson SC , Koscik RL , Jonaitis EM , et al. The Wisconsin Registry for Alzheimer's Prevention: a review of findings and current directions. Alzheimers Dement (Amst). 2018;10:130‐142.29322089)
Johnson SC , Koscik RL , Jonaitis EM , et al. The Wisconsin Registry for Alzheimer's Prevention: a review of findings and current directions. Alzheimers Dement (Amst). 2018;10:130‐142.29322089Johnson SC , Koscik RL , Jonaitis EM , et al. The Wisconsin Registry for Alzheimer's Prevention: a review of findings and current directions. Alzheimers Dement (Amst). 2018;10:130‐142.29322089, Johnson SC , Koscik RL , Jonaitis EM , et al. The Wisconsin Registry for Alzheimer's Prevention: a review of findings and current directions. Alzheimers Dement (Amst). 2018;10:130‐142.29322089
-
( Scheltens P , Blennow K , Breteler MM , et al. Alzheimer's disease. Lancet. 2016;388:505‐517.26921134)
Scheltens P , Blennow K , Breteler MM , et al. Alzheimer's disease. Lancet. 2016;388:505‐517.26921134Scheltens P , Blennow K , Breteler MM , et al. Alzheimer's disease. Lancet. 2016;388:505‐517.26921134, Scheltens P , Blennow K , Breteler MM , et al. Alzheimer's disease. Lancet. 2016;388:505‐517.26921134
-
J. Langbaum, J. Karlawish, J. Roberts, E. Wood, A. Bradbury, N. High, T. Walsh, D. Gordon, Raj Aggarwal, Patricia Davis, C. Stowell, Lane Trisko, C. Langlois, E. Reiman, P. Tariot (2019)
GeneMatch: A novel recruitment registry using at-home APOE genotyping to enhance referrals to Alzheimer's prevention studiesAlzheimer's & Dementia, 15
-
( Fruijtier AD , Visser LNC , van Maurik IS , et al. ABIDE Delphi study: topics to discuss in diagnostic consultations in memory clinics. Alzheimers Res Ther. 2019;11:77.31472676)
Fruijtier AD , Visser LNC , van Maurik IS , et al. ABIDE Delphi study: topics to discuss in diagnostic consultations in memory clinics. Alzheimers Res Ther. 2019;11:77.31472676Fruijtier AD , Visser LNC , van Maurik IS , et al. ABIDE Delphi study: topics to discuss in diagnostic consultations in memory clinics. Alzheimers Res Ther. 2019;11:77.31472676, Fruijtier AD , Visser LNC , van Maurik IS , et al. ABIDE Delphi study: topics to discuss in diagnostic consultations in memory clinics. Alzheimers Res Ther. 2019;11:77.31472676
-
O. Rodríguez‐Gomez, Adrián Rodrigo, F. Iradier, M. Santos-Santos, H. Hundemer, A. Ciudin, Lena Sannemann, M. Zwan, B. Glaysher, A. Wimo, Jaka Bonn, G. Johansson, Isabel Rodriguez, M. Alegret, D. Gove, Susana Pinó, Paloma Trigueros, M. Kivipelto, B. Mathews, A. Ciudad, D. Ferreira, Christophe Bintener, M. Gurruchaga, E. Westman, M. Belger, S. Valero, P. Maguire, D. Krivec, M. Kramberger, R. Simó, Inmaculada Garro, P. Visser, Annette Dumas, J. Georges, F. Jessen, B. Winblad, C. Shering, Neil Stewart, Laura Campo, M. Boada (2019)
The MOPEAD project: Advancing patient engagement for the detection of “hidden” undiagnosed cases of Alzheimer's disease in the communityAlzheimer's & Dementia, 15
-
Sarah-Naomi James, Christopher Lane, T. Parker, Kirsty Lu, Jessica Collins, Heidi Murray-Smith, M. Byford, A. Wong, A. Keshavan, S. Buchanan, S. Keuss, D. Kuh, Nick Fox, J. Schott, M. Richards (2018)
Using a birth cohort to study brain health and preclinical dementia: recruitment and participation rates in Insight 46BMC Research Notes, 11
-
F. Matcham, C. Pietro, V. Bulgari, G. Girolamo, R. Dobson, H. Eriksson, A. Folarin, J. Haro, M. Kerz, F. Lamers, Q. Li, N. Manyakov, D. Mohr, I. Myin-Germeys, V. Narayan, Penninx Bwjh, Y. Ranjan, Z. Rashid, A. Rintala, S. Siddi, S. Simblett, T. Wykes, M. Hotopf, Sonia Ringkjøbing, S. Difrancesco, K. White, A. Ivan, A. Polhemus, José Ferrão, Michiel Ringkjøbing-Elema, Francesco Nobilia, W. Viechtbauer, S. Peelen, Z. Rashid, Janneke Boere, N. Cummins, N. Meyer (2019)
Remote assessment of disease and relapse in major depressive disorder (RADAR-MDD): a multi-centre prospective cohort study protocolBMC Psychiatry, 19
-
Sterling Johnson, R. Koscik, E. Jonaitis, L. Clark, Kimberly Mueller, S. Berman, B. Bendlin, C. Engelman, O. Okonkwo, K. Hogan, S. Asthana, C. Carlsson, B. Hermann, M. Sager (2017)
The Wisconsin Registry for Alzheimer's Prevention: A review of findings and current directionsAlzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring, 10
-
( Statistics Netherlands . Internet; toegang, gebruik en faciliteiten; 2012–2019. 08‐10‐2019. https://opendata.cbs.nl/statline/#/CBS/nl/dataset/83429NED/table?dl=3AC09 )
Statistics Netherlands . Internet; toegang, gebruik en faciliteiten; 2012–2019. 08‐10‐2019. https://opendata.cbs.nl/statline/#/CBS/nl/dataset/83429NED/table?dl=3AC09Statistics Netherlands . Internet; toegang, gebruik en faciliteiten; 2012–2019. 08‐10‐2019. https://opendata.cbs.nl/statline/#/CBS/nl/dataset/83429NED/table?dl=3AC09 , Statistics Netherlands . Internet; toegang, gebruik en faciliteiten; 2012–2019. 08‐10‐2019. https://opendata.cbs.nl/statline/#/CBS/nl/dataset/83429NED/table?dl=3AC09
-
( Molinuevo JL , Gramunt N , Gispert JD , et al. The ALFA project: a research platform to identify early pathophysiological features of Alzheimer's disease. Alzheimers Dement (N Y). 2016;2:82‐92.29067295)
Molinuevo JL , Gramunt N , Gispert JD , et al. The ALFA project: a research platform to identify early pathophysiological features of Alzheimer's disease. Alzheimers Dement (N Y). 2016;2:82‐92.29067295Molinuevo JL , Gramunt N , Gispert JD , et al. The ALFA project: a research platform to identify early pathophysiological features of Alzheimer's disease. Alzheimers Dement (N Y). 2016;2:82‐92.29067295, Molinuevo JL , Gramunt N , Gispert JD , et al. The ALFA project: a research platform to identify early pathophysiological features of Alzheimer's disease. Alzheimers Dement (N Y). 2016;2:82‐92.29067295
-
( Legdeur N , Badissi M , Carter SF , et al. Resilience to cognitive impairment in the oldest‐old: design of the EMIF‐AD 90+ study. BMC Geriatr. 2018;18:289.30477432)
Legdeur N , Badissi M , Carter SF , et al. Resilience to cognitive impairment in the oldest‐old: design of the EMIF‐AD 90+ study. BMC Geriatr. 2018;18:289.30477432Legdeur N , Badissi M , Carter SF , et al. Resilience to cognitive impairment in the oldest‐old: design of the EMIF‐AD 90+ study. BMC Geriatr. 2018;18:289.30477432, Legdeur N , Badissi M , Carter SF , et al. Resilience to cognitive impairment in the oldest‐old: design of the EMIF‐AD 90+ study. BMC Geriatr. 2018;18:289.30477432
-
( Rodriguez‐Gomez O , Rodrigo A , Iradier F , et al. The MOPEAD project: advancing patient engagement for the detection of “hidden” undiagnosed cases of Alzheimer's disease in the community. Alzheimers Dement. 2019;15:828‐839.31076376)
Rodriguez‐Gomez O , Rodrigo A , Iradier F , et al. The MOPEAD project: advancing patient engagement for the detection of “hidden” undiagnosed cases of Alzheimer's disease in the community. Alzheimers Dement. 2019;15:828‐839.31076376Rodriguez‐Gomez O , Rodrigo A , Iradier F , et al. The MOPEAD project: advancing patient engagement for the detection of “hidden” undiagnosed cases of Alzheimer's disease in the community. Alzheimers Dement. 2019;15:828‐839.31076376, Rodriguez‐Gomez O , Rodrigo A , Iradier F , et al. The MOPEAD project: advancing patient engagement for the detection of “hidden” undiagnosed cases of Alzheimer's disease in the community. Alzheimers Dement. 2019;15:828‐839.31076376
-
M. Weiner, R. Nosheny, M. Camacho, Diana Truran-Sacrey, R. Mackin, D. Flenniken, A. Ulbricht, Philip Insel, Shannon Finley, J. Fockler, D. Veitch (2018)
The Brain Health Registry: An internet-based platform for recruitment, assessment, and longitudinal monitoring of participants for neuroscience studiesAlzheimer's & Dementia, 14
-
C. Ferri, M. Prince, C. Brayne, H. Brodaty, L. Fratiglioni, M. Ganguli, K. Hall, K. Hasegawa, H. Hendrie, Yueqin Huang, Anthony Jorm, C. Mathers, P. Menezes, E. Rimmer, M. Scazufca (2005)
Global prevalence of dementia: a Delphi consensus studyThe Lancet, 366
-
P. Aisen, J. Touchon, S. Andrieu, M. Boada, R. Doody, R. Nosheny, J. Langbaum, L. Schneider, S. Hendrix, G. Wilcock, J. Molinuevo, C. Ritchie, P. Ousset, J. Cummings, R. Sperling, S. DeKosky, S. Lovestone, H. Hampel, R. Petersen, V. Legrand, M. Egan, C. Randolph, S. Salloway, M. Weiner, B. Vellas (2016)
Registries and Cohorts to Accelerate Early Phase Alzheimer's Trials. A Report from the E.U./U.S. Clinical Trials in Alzheimer's Disease Task Force.The journal of prevention of Alzheimer's disease, 3 2
-
A. Fruijtier, L. Visser, Ingrid Maurik, M. Zwan, F. Bouwman, W. Flier, E. Smets (2019)
ABIDE Delphi study: topics to discuss in diagnostic consultations in memory clinicsAlzheimer's Research & Therapy, 11
-
(2017)
Design of the ExCersion-VCI study: the effect of aerobic exercise on cerebral perfusion in patientswith vascular cognitive impairment.Alzheimers -
F. Jessen, R. Amariglio, R. Buckley, W. Flier, Ying Han, J. Molinuevo, L. Rabin, D. Rentz, O. Rodríguez‐Gomez, A. Saykin, S. Sikkes, C. Smart, S. Wolfsgruber, M. Wagner (2020)
The characterisation of subjective cognitive declineThe Lancet Neurology, 19
-
( Weiner MW , Nosheny R , Camacho M , et al. The Brain Health Registry: an internet‐based platform for recruitment, assessment, and longitudinal monitoring of participants for neuroscience studies. Alzheimers Dement. 2018;14:1063‐1076.29754989)
Weiner MW , Nosheny R , Camacho M , et al. The Brain Health Registry: an internet‐based platform for recruitment, assessment, and longitudinal monitoring of participants for neuroscience studies. Alzheimers Dement. 2018;14:1063‐1076.29754989Weiner MW , Nosheny R , Camacho M , et al. The Brain Health Registry: an internet‐based platform for recruitment, assessment, and longitudinal monitoring of participants for neuroscience studies. Alzheimers Dement. 2018;14:1063‐1076.29754989, Weiner MW , Nosheny R , Camacho M , et al. The Brain Health Registry: an internet‐based platform for recruitment, assessment, and longitudinal monitoring of participants for neuroscience studies. Alzheimers Dement. 2018;14:1063‐1076.29754989
-
(2012)
Internet; toegang, gebruik en faciliteiten -
F. Verhage (1964)
Intelligentie en leeftijd : onderzoek bij Nederlanders van twaalf tot zevenenzeventig jaar -
( Lever‐van Milligen BA , Verhoeven JE , Schmaal L , et al. The impact of depression and anxiety treatment on biological aging and metabolic stress: study protocol of the MOod treatment with antidepressants or running (MOTAR) study. BMC Psychiatry. 2019;19:425.31888565)
Lever‐van Milligen BA , Verhoeven JE , Schmaal L , et al. The impact of depression and anxiety treatment on biological aging and metabolic stress: study protocol of the MOod treatment with antidepressants or running (MOTAR) study. BMC Psychiatry. 2019;19:425.31888565Lever‐van Milligen BA , Verhoeven JE , Schmaal L , et al. The impact of depression and anxiety treatment on biological aging and metabolic stress: study protocol of the MOod treatment with antidepressants or running (MOTAR) study. BMC Psychiatry. 2019;19:425.31888565, Lever‐van Milligen BA , Verhoeven JE , Schmaal L , et al. The impact of depression and anxiety treatment on biological aging and metabolic stress: study protocol of the MOod treatment with antidepressants or running (MOTAR) study. BMC Psychiatry. 2019;19:425.31888565
-
J. Molinuevo, N. Gramunt, J. Gispert, K. Fauria, M. Esteller, C. Minguillón, G. Sánchez-Benavides, Gema Huesa, S. Moran, R. Dal-Ré, J. Camí (2016)
The ALFA project: A research platform to identify early pathophysiological features of Alzheimer's diseaseAlzheimer's & Dementia : Translational Research & Clinical Interventions, 2
-
( Ferri CP , Prince M , Brayne C , et al. Global prevalence of dementia: a Delphi consensus study. Lancet. 2005;366:2112‐21127.16360788)
Ferri CP , Prince M , Brayne C , et al. Global prevalence of dementia: a Delphi consensus study. Lancet. 2005;366:2112‐21127.16360788Ferri CP , Prince M , Brayne C , et al. Global prevalence of dementia: a Delphi consensus study. Lancet. 2005;366:2112‐21127.16360788, Ferri CP , Prince M , Brayne C , et al. Global prevalence of dementia: a Delphi consensus study. Lancet. 2005;366:2112‐21127.16360788
-
R. Jutten, J. Harrison, F. Jong, A. Aleman, C. Ritchie, P. Scheltens, S. Sikkes (2017)
A composite measure of cognitive and functional progression in Alzheimer's disease: Design of the Capturing Changes in Cognition studyAlzheimer's & Dementia : Translational Research & Clinical Interventions, 3
-
( Matcham F , Barattieri di San Pietro C , Bulgari V , de Girolamo G , Dobson R , Eriksson H , et al. Remote assessment of disease and relapse in major depressive disorder (RADAR‐MDD): a multi‐centre prospective cohort study protocol. BMC Psychiatry. 2019;19:72.30777041)
Matcham F , Barattieri di San Pietro C , Bulgari V , de Girolamo G , Dobson R , Eriksson H , et al. Remote assessment of disease and relapse in major depressive disorder (RADAR‐MDD): a multi‐centre prospective cohort study protocol. BMC Psychiatry. 2019;19:72.30777041Matcham F , Barattieri di San Pietro C , Bulgari V , de Girolamo G , Dobson R , Eriksson H , et al. Remote assessment of disease and relapse in major depressive disorder (RADAR‐MDD): a multi‐centre prospective cohort study protocol. BMC Psychiatry. 2019;19:72.30777041, Matcham F , Barattieri di San Pietro C , Bulgari V , de Girolamo G , Dobson R , Eriksson H , et al. Remote assessment of disease and relapse in major depressive disorder (RADAR‐MDD): a multi‐centre prospective cohort study protocol. BMC Psychiatry. 2019;19:72.30777041
-
( Bilderbeck AC , Penninx B , Arango C , et al. Overview of the clinical implementation of a study exploring social withdrawal in patients with schizophrenia and Alzheimer's disease. Neurosci Biobehav Rev. 2019;97:87‐93.29940238)
Bilderbeck AC , Penninx B , Arango C , et al. Overview of the clinical implementation of a study exploring social withdrawal in patients with schizophrenia and Alzheimer's disease. Neurosci Biobehav Rev. 2019;97:87‐93.29940238Bilderbeck AC , Penninx B , Arango C , et al. Overview of the clinical implementation of a study exploring social withdrawal in patients with schizophrenia and Alzheimer's disease. Neurosci Biobehav Rev. 2019;97:87‐93.29940238, Bilderbeck AC , Penninx B , Arango C , et al. Overview of the clinical implementation of a study exploring social withdrawal in patients with schizophrenia and Alzheimer's disease. Neurosci Biobehav Rev. 2019;97:87‐93.29940238
-
( Leeuwis AE , Hooghiemstra AM , Amier R , et al. Design of the ExCersion‐VCI study: the effect of aerobic exercise on cerebral perfusion in patients with vascular cognitive impairment. Alzheimers Dement (N Y). 2017;3:157‐165.29067325)
Leeuwis AE , Hooghiemstra AM , Amier R , et al. Design of the ExCersion‐VCI study: the effect of aerobic exercise on cerebral perfusion in patients with vascular cognitive impairment. Alzheimers Dement (N Y). 2017;3:157‐165.29067325Leeuwis AE , Hooghiemstra AM , Amier R , et al. Design of the ExCersion‐VCI study: the effect of aerobic exercise on cerebral perfusion in patients with vascular cognitive impairment. Alzheimers Dement (N Y). 2017;3:157‐165.29067325, Leeuwis AE , Hooghiemstra AM , Amier R , et al. Design of the ExCersion‐VCI study: the effect of aerobic exercise on cerebral perfusion in patients with vascular cognitive impairment. Alzheimers Dement (N Y). 2017;3:157‐165.29067325
-
(2020)
Prescreening forEuropean Prevention of Alzheimer Dementia (EPAD) trial-ready cohort: impact of AD risk factors and recruitment -
( Langbaum JB , Karlawish J , Roberts JS , et al. GeneMatch: a novel recruitment registry using at‐home APOE genotyping to enhance referrals to Alzheimer's prevention studies. Alzheimers Dement. 2019;15:515‐524.30772251)
Langbaum JB , Karlawish J , Roberts JS , et al. GeneMatch: a novel recruitment registry using at‐home APOE genotyping to enhance referrals to Alzheimer's prevention studies. Alzheimers Dement. 2019;15:515‐524.30772251Langbaum JB , Karlawish J , Roberts JS , et al. GeneMatch: a novel recruitment registry using at‐home APOE genotyping to enhance referrals to Alzheimer's prevention studies. Alzheimers Dement. 2019;15:515‐524.30772251, Langbaum JB , Karlawish J , Roberts JS , et al. GeneMatch: a novel recruitment registry using at‐home APOE genotyping to enhance referrals to Alzheimer's prevention studies. Alzheimers Dement. 2019;15:515‐524.30772251
-
K. Fargo, M. Carrillo, M. Weiner, W. Potter, Z. Khachaturian (2016)
The crisis in recruitment for clinical trials in Alzheimer's and dementia: An action plan for solutionsAlzheimer's & Dementia, 12
-
( Aisen P , Touchon J , Andrieu S , et al. Registries and Cohorts to Accelerate Early Phase Alzheimer's Trials. A Report from the E.U./U.S. Clinical Trials in Alzheimer's Disease Task Force. J Prev Alzheimers Dis. 2016;3:68‐74.29210442)
Aisen P , Touchon J , Andrieu S , et al. Registries and Cohorts to Accelerate Early Phase Alzheimer's Trials. A Report from the E.U./U.S. Clinical Trials in Alzheimer's Disease Task Force. J Prev Alzheimers Dis. 2016;3:68‐74.29210442Aisen P , Touchon J , Andrieu S , et al. Registries and Cohorts to Accelerate Early Phase Alzheimer's Trials. A Report from the E.U./U.S. Clinical Trials in Alzheimer's Disease Task Force. J Prev Alzheimers Dis. 2016;3:68‐74.29210442, Aisen P , Touchon J , Andrieu S , et al. Registries and Cohorts to Accelerate Early Phase Alzheimer's Trials. A Report from the E.U./U.S. Clinical Trials in Alzheimer's Disease Task Force. J Prev Alzheimers Dis. 2016;3:68‐74.29210442
-
( James SN , Lane CA , Parker TD , et al. Using a birth cohort to study brain health and preclinical dementia: recruitment and participation rates in Insight 46. BMC Res Notes. 2018;11:885.30545411)
James SN , Lane CA , Parker TD , et al. Using a birth cohort to study brain health and preclinical dementia: recruitment and participation rates in Insight 46. BMC Res Notes. 2018;11:885.30545411James SN , Lane CA , Parker TD , et al. Using a birth cohort to study brain health and preclinical dementia: recruitment and participation rates in Insight 46. BMC Res Notes. 2018;11:885.30545411, James SN , Lane CA , Parker TD , et al. Using a birth cohort to study brain health and preclinical dementia: recruitment and participation rates in Insight 46. BMC Res Notes. 2018;11:885.30545411
-
( Fargo KN , Carrillo MC , Weiner MW , Potter WZ , Khachaturian Z . The crisis in recruitment for clinical trials in Alzheimer's and dementia: an action plan for solutions. Alzheimers Dement. 2016;12:1113‐1115.27836052)
Fargo KN , Carrillo MC , Weiner MW , Potter WZ , Khachaturian Z . The crisis in recruitment for clinical trials in Alzheimer's and dementia: an action plan for solutions. Alzheimers Dement. 2016;12:1113‐1115.27836052Fargo KN , Carrillo MC , Weiner MW , Potter WZ , Khachaturian Z . The crisis in recruitment for clinical trials in Alzheimer's and dementia: an action plan for solutions. Alzheimers Dement. 2016;12:1113‐1115.27836052, Fargo KN , Carrillo MC , Weiner MW , Potter WZ , Khachaturian Z . The crisis in recruitment for clinical trials in Alzheimer's and dementia: an action plan for solutions. Alzheimers Dement. 2016;12:1113‐1115.27836052
-
L. Vermunt, G. Muniz-Terrera, Lea Meulen, C. Veal, K. Blennow, A. Campbell, I. Carrié, J. Delrieu, K. Fauria, Gema Rodríguez, S. Ingala, N. Jenkins, J. Molinuevo, P. Ousset, D. Porteous, N. Prins, A. Solomon, B. Tom, H. Zetterberg, M. Zwan, C. Ritchie, P. Scheltens, Gérald Luscan, A. Brookes, P. Visser (2020)
Prescreening for European Prevention of Alzheimer Dementia (EPAD) trial-ready cohort: impact of AD risk factors and recruitment settingsAlzheimer's Research & Therapy, 12
-
( Jessen F , Amariglio RE , Buckley RF , et al. The characterisation of subjective cognitive decline. Lancet Neurol. 2020;19:271‐278.31958406)
Jessen F , Amariglio RE , Buckley RF , et al. The characterisation of subjective cognitive decline. Lancet Neurol. 2020;19:271‐278.31958406Jessen F , Amariglio RE , Buckley RF , et al. The characterisation of subjective cognitive decline. Lancet Neurol. 2020;19:271‐278.31958406, Jessen F , Amariglio RE , Buckley RF , et al. The characterisation of subjective cognitive decline. Lancet Neurol. 2020;19:271‐278.31958406
-
D. Selkoe (2011)
Alzheimer's disease.Cold Spring Harbor perspectives in biology, 3 7
-
Bianca Milligen, J. Verhoeven, L. Schmaal, L. Velzen, D. Révész, C. Black, Laura Han, M. Horsfall, N. Batelaan, A. Balkom, D. Schaik, P. Oppen, B. Penninx (2019)
The impact of depression and anxiety treatment on biological aging and metabolic stress: study protocol of the MOod treatment with antidepressants or running (MOTAR) studyBMC Psychiatry, 19
-
A. Leeuwis, A. Hooghiemstra, R. Amier, D. Ferro, L. Franken, R. Nijveldt, J. Kuijer, Anne-Sophie Bronzwaer, J. Lieshout, M. Rietberg, J. Veerbeek, R. Huijsmans, F. Backx, C. Teunissen, E. Bron, F. Barkhof, N. Prins, R. Shahzad, W. Niessen, A. Roos, M. Osch, A. Rossum, G. Biessels, W. Flier (2017)
Design of the ExCersion-VCI study: The effect of aerobic exercise on cerebral perfusion in patients with vascular cognitive impairmentAlzheimer's & Dementia : Translational Research & Clinical Interventions, 3
-
R. Slot, S. Verfaillie, J. Overbeek, T. Timmers, L. Wesselman, C. Teunissen, A. Dols, F. Bouwman, N. Prins, F. Barkhof, A. Lammertsma, B. Berckel, P. Scheltens, S. Sikkes, W. Flier (2018)
Subjective Cognitive Impairment Cohort (SCIENCe): study design and first resultsAlzheimer's Research & Therapy, 10
-
Boehringer Ingelheim and Aribio. He is co-PI of a study with Fuji Film REFERENCES -
A. Solomon, M. Kivipelto, J. Molinuevo, B. Tom, C. Ritchie (2018)
European Prevention of Alzheimer’s Dementia Longitudinal Cohort Study (EPAD LCS): study protocolBMJ Open, 8
-
A. Bilderbeck, B. Penninx, C. Arango, N. Wee, R. Kahn, I. Rossum, A. Hayen, M. Kas, A. Post, G. Dawson (2019)
Overview of the clinical implementation of a study exploring social withdrawal in patients with schizophrenia and Alzheimer’s diseaseNeuroscience & Biobehavioral Reviews, 97
-
( Vermunt L , Muniz‐Terrera G , Ter Meulen L , et al. Prescreening for European Prevention of Alzheimer Dementia (EPAD) trial‐ready cohort: impact of AD risk factors and recruitment settings. Alzheimers Res Ther. 2020;12:8.31907067)
Vermunt L , Muniz‐Terrera G , Ter Meulen L , et al. Prescreening for European Prevention of Alzheimer Dementia (EPAD) trial‐ready cohort: impact of AD risk factors and recruitment settings. Alzheimers Res Ther. 2020;12:8.31907067Vermunt L , Muniz‐Terrera G , Ter Meulen L , et al. Prescreening for European Prevention of Alzheimer Dementia (EPAD) trial‐ready cohort: impact of AD risk factors and recruitment settings. Alzheimers Res Ther. 2020;12:8.31907067, Vermunt L , Muniz‐Terrera G , Ter Meulen L , et al. Prescreening for European Prevention of Alzheimer Dementia (EPAD) trial‐ready cohort: impact of AD risk factors and recruitment settings. Alzheimers Res Ther. 2020;12:8.31907067
-
( Gilmore‐Bykovskyi AL , Jin Y , Gleason C , et al. Recruitment and retention of underrepresented populations in Alzheimer's disease research: a systematic review. Alzheimers Dement (N Y). 2019;5:751‐770.31921966)
Gilmore‐Bykovskyi AL , Jin Y , Gleason C , et al. Recruitment and retention of underrepresented populations in Alzheimer's disease research: a systematic review. Alzheimers Dement (N Y). 2019;5:751‐770.31921966Gilmore‐Bykovskyi AL , Jin Y , Gleason C , et al. Recruitment and retention of underrepresented populations in Alzheimer's disease research: a systematic review. Alzheimers Dement (N Y). 2019;5:751‐770.31921966, Gilmore‐Bykovskyi AL , Jin Y , Gleason C , et al. Recruitment and retention of underrepresented populations in Alzheimer's disease research: a systematic review. Alzheimers Dement (N Y). 2019;5:751‐770.31921966
-
T. Balkom, H. Berendse, Y. Werf, J. Twisk, I. Zijlstra, R. Hagen, T. Berk, C. Vriend, O. Heuvel (2019)
COGTIPS: a double-blind randomized active controlled trial protocol to study the effect of home-based, online cognitive training on cognition and brain networks in Parkinson’s diseaseBMC Neurology, 19
-
( Jutten RJ , Harrison J , de Jong FJ , et al. A composite measure of cognitive and functional progression in Alzheimer's disease: design of the Capturing Changes in Cognition study. Alzheimers Dement (N Y). 2017;3:130‐138.29067324)
Jutten RJ , Harrison J , de Jong FJ , et al. A composite measure of cognitive and functional progression in Alzheimer's disease: design of the Capturing Changes in Cognition study. Alzheimers Dement (N Y). 2017;3:130‐138.29067324Jutten RJ , Harrison J , de Jong FJ , et al. A composite measure of cognitive and functional progression in Alzheimer's disease: design of the Capturing Changes in Cognition study. Alzheimers Dement (N Y). 2017;3:130‐138.29067324, Jutten RJ , Harrison J , de Jong FJ , et al. A composite measure of cognitive and functional progression in Alzheimer's disease: design of the Capturing Changes in Cognition study. Alzheimers Dement (N Y). 2017;3:130‐138.29067324
-
( van Balkom TD , Berendse HW , van der Werf YD , et al. COGTIPS: a double‐blind randomized active controlled trial protocol to study the effect of home‐based, online cognitive training on cognition and brain networks in Parkinson's disease. BMC Neurol. 2019;19:179.31366395)
van Balkom TD , Berendse HW , van der Werf YD , et al. COGTIPS: a double‐blind randomized active controlled trial protocol to study the effect of home‐based, online cognitive training on cognition and brain networks in Parkinson's disease. BMC Neurol. 2019;19:179.31366395van Balkom TD , Berendse HW , van der Werf YD , et al. COGTIPS: a double‐blind randomized active controlled trial protocol to study the effect of home‐based, online cognitive training on cognition and brain networks in Parkinson's disease. BMC Neurol. 2019;19:179.31366395, van Balkom TD , Berendse HW , van der Werf YD , et al. COGTIPS: a double‐blind randomized active controlled trial protocol to study the effect of home‐based, online cognitive training on cognition and brain networks in Parkinson's disease. BMC Neurol. 2019;19:179.31366395
-
(2019)
European Prevention ofAlzheimer’sDementia Longitudinal Cohort Study (EPAD LCS): study protocol. BMJOpen. 2019;8:e021017 -
N. Legdeur, M. Badissi, Stephen Carter, Sophie Crom, Aleid Kreeke, R. Vreeswijk, M. Trappenburg, M. Oudega, H. Koek, J. Campen, C. Keijsers, Chinenye Amadi, R. Hinz, M. Gordon, G. Novak, J. Podhorná, E. Serné, F. Verbraak, M. Yaqub, A. Hillebrand, A. Griffa, N. Pendleton, S. Kramer, C. Teunissen, A. Lammertsma, F. Barkhof, B. Berckel, P. Scheltens, M. Muller, A. Maier, K. Herholz, P. Visser (2018)
Resilience to cognitive impairment in the oldest-old: design of the EMIF-AD 90+ studyBMC Geriatrics, 18
-
I've never smoked 2. yes, at the moment 3. yes, in the past Abbreviations: CVA, cerebrovascular accident; MCI, mild cognitive impairment -
( Verhage F , Intelligentie en leeftijd: onderzoek bij Nederlanders van twaalf tot zevenenzeventig jaar. Assen: Van Gorcum; 1964.)
Verhage F , Intelligentie en leeftijd: onderzoek bij Nederlanders van twaalf tot zevenenzeventig jaar. Assen: Van Gorcum; 1964.Verhage F , Intelligentie en leeftijd: onderzoek bij Nederlanders van twaalf tot zevenenzeventig jaar. Assen: Van Gorcum; 1964., Verhage F , Intelligentie en leeftijd: onderzoek bij Nederlanders van twaalf tot zevenenzeventig jaar. Assen: Van Gorcum; 1964.
-
( Solomon A , Kivipelto M , Molinuevo JL , Tom B , Ritchie CW . European Prevention of Alzheimer's Dementia Longitudinal Cohort Study (EPAD LCS): study protocol. BMJ Open. 2019;8:e021017.)
Solomon A , Kivipelto M , Molinuevo JL , Tom B , Ritchie CW . European Prevention of Alzheimer's Dementia Longitudinal Cohort Study (EPAD LCS): study protocol. BMJ Open. 2019;8:e021017.Solomon A , Kivipelto M , Molinuevo JL , Tom B , Ritchie CW . European Prevention of Alzheimer's Dementia Longitudinal Cohort Study (EPAD LCS): study protocol. BMJ Open. 2019;8:e021017., Solomon A , Kivipelto M , Molinuevo JL , Tom B , Ritchie CW . European Prevention of Alzheimer's Dementia Longitudinal Cohort Study (EPAD LCS): study protocol. BMJ Open. 2019;8:e021017.
-
( Slot RER , Verfaillie SCJ , Overbeek JM , et al. Subjective Cognitive Impairment Cohort (SCIENCe): study design and first results. Alzheimers Res Ther. 2018;10:76.30081935)
Slot RER , Verfaillie SCJ , Overbeek JM , et al. Subjective Cognitive Impairment Cohort (SCIENCe): study design and first results. Alzheimers Res Ther. 2018;10:76.30081935Slot RER , Verfaillie SCJ , Overbeek JM , et al. Subjective Cognitive Impairment Cohort (SCIENCe): study design and first results. Alzheimers Res Ther. 2018;10:76.30081935, Slot RER , Verfaillie SCJ , Overbeek JM , et al. Subjective Cognitive Impairment Cohort (SCIENCe): study design and first results. Alzheimers Res Ther. 2018;10:76.30081935
- Publisher
- Wiley
- Copyright
- © 2021 the Alzheimer's Association
- ISSN
- 2352-8737
- eISSN
- 2352-8737
- DOI
- 10.1002/trc2.12132
- Publisher site
- See Article on Publisher Site
Abstract
Journal
Alzheimer's & Dementia: Translational Research & Clinical Interventions – Wiley
Published: Jan 1, 2021
Keywords: ; ; ; ; ; ; ; ;